CCL Products (India) Ltd (CCL)
🎯 Key Takeaways
- CCL Products (India) Ltd is transitioning from a mature, stable FMCG player into a growth-oriented phase, leveraging strong branded sales momentum and international expansion to drive volume growth, while maintaining disciplined capital allocation and balance sheet strength. Management is prioritizing profitability and debt reduction over aggressive capex, signaling a strategic shift toward sustainable, utilization-driven expansion.
- Revenue declined 2% QoQ to ₹1,200 in Q1FY27.
- ⚠️ Margin pressure from rupee depreciation and El Niño-related supply disruptions remains a concern, as explicitly flagged by management despite current
📖 The Story
CCL Products (India) Ltd is transitioning from a mature, stable FMCG player into a growth-oriented phase, leveraging strong branded sales momentum and international expansion to drive volume growth, while maintaining disciplined capital allocation and balance sheet strength. Management is prioritizing profitability and debt reduction over aggressive capex, signaling a strategic shift toward sustainable, utilization-driven expansion.
📰 What's Happening
In Q1 FY27, CCL reported a 13.76% YoY revenue increase to ₹1,203.59 crores, fueled by 20% volume growth and branded sales targeting INR550-600 crores for FY27. Net profit surged 61.31% to ₹[amount context mismatch]7 crores, and EBITDA rose 21.84% to ₹196.69 crores, with EBITDA per kg stable at ₹135–140 due to cost-plus pricing and freeze-dried demand. Net debt declined to ₹963 crores from ₹1,073 crores, with gross debt targeted at ₹1,000 crores by FY27. Volume growth guidance was raised to 15% for the full year, and international markets (Percol UK/US) are expanding. No major capex is planned beyond small upgrades, with INR25-50 crores allocated for FY27. Management emphasized that expansion will occur only beyond 85% capacity utilization, currently at 77%.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | 1,127 | 1,051 | 1,224 | 1,200 |
| Operating Profit | 158 | 146 | 151 | 155 |
| OPM % | 14.0% | 13.9% | 12.4% | 12.9% |
| Net Profit | 101 | 100 | 115 | 117 |
| EPS | ₹7.57 | ₹7.53 | ₹8.60 | ₹8.77 |
The company is demonstrating accelerating profitability and margin resilience despite macro headwinds, as evidenced by 61% net profit growth and stable EBITDA per kg in Q1 FY27, even as revenue grew at 13.76%. This performance is supported by strong branded sales execution and cost discipline, offsetting rupee depreciation and El Niño-related supply risks. The consistent improvement in OPM (12.9% in Jun 2026 vs. 13.9% in Dec 2025) and EPS growth from ₹7.53 to ₹8.77 over four quarters reflects operational efficiency. Management’s focus on volume growth (15% guidance) and branded sales targets (INR550-600 crores) suggests a deliberate scaling of high-margin segments, while deferred capex indicates capital discipline.
🔮 Management Outlook & What's Next
Management has provided clear forward guidance: INR550-600 crores in branded sales for FY27, 15% full-year volume growth, gross debt target of ₹1,000 crores, and net debt target of ₹800 crores. EBITDA per kg is expected to remain stable at ₹135–140, and international markets (Percol UK/US) are to expand. No major M&A or large-scale capex is planned beyond small upgrades. Expansion is contingent on capacity utilization exceeding 85%, indicating a cautious, metrics-driven approach to growth. No explicit timeline or target for ROCE or margin improvement was provided beyond current stability.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 27 | 27 | 27 | 27 |
| Reserves | 1,781 | 1,941 | 2,060 | 2,318 |
| Borrowings | 1,975 | 1,813 | 1,628 | 1,324 |
| Total Liabilities | 4,023 | 4,241 | 4,288 | 4,326 |
| Fixed Assets | 1,233 | 1,622 | 2,027 | 2,027 |
| Investments | 0 | 0 | 0 | 3 |
| Total Assets | 4,023 | 4,241 | 4,288 | 4,326 |
The balance sheet reflects a deliberate and disciplined deleveraging trajectory, with net debt declining to ₹963 crores in Q1 FY27 from higher levels, and gross debt targeted at ₹1,000 crores by FY27. Equity and reserves remain stable at ₹27 crores and ₹2,318 crores respectively as of Mar 2026, while borrowings have decreased from ₹1,813 crores (Mar 2025) to ₹1,324 crores (Mar 2026), indicating active debt reduction. This trend supports improved financial flexibility and reduces interest burden, aligning with management’s focus on strengthening credit metrics and lender confidence, as reinforced by the recent AA rating from ICRA.
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | +290 |
| Investing | -416 |
| Financing | +53 |
| Net Cash Flow | -73 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 46.1% | 46.1% | 46.1% | 46.1% |
| FII | 10.5% | 11.0% | 11.2% | 12.1% |
| DII | 21.8% | 21.5% | 21.4% | 21.1% |
| Public | 10.3% | 10.2% | 10.0% | 9.8% |
| # Shareholders | 55,690 | 60,552 | 62,293 | 63,904 |
Institutional investor interest is rising, with FII holding increasing from 10.53% in Q2FY26 to 12.07% in Q1FY27, and DII from 21.83% to 21.1% — though DII slightly declined in the latest quarter. Promoter holding remains stable near 46.11%, indicating no dilution or sell-off. The growing number of shareholders (63,904 in Q1FY27 vs. 55,690 in Q2FY26) suggests rising retail participation. The absence of significant promoter selling or large institutional exits signals confidence in the company’s trajectory, while the steady accumulation by FIIs may reflect growing recognition of its improving fundamentals and debt management.
⚖️ Peer Comparison — Plantation & Plantation Products
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| CCL | 14,691 | 33.9 | 16.4% | 22.0% | 0.92 |
| PIXTRANS | 2,429 | 18.4 | 24.8% | 18.9% | 0.03 |
| TINNARUBR | 1,839 | 29.3 | 30.3% | 34.6% | 0.75 |
| GRPLTD | 1,082 | 190.8 | 7.4% | 3.2% | 1.16 |
| GOODRICKE | 522 | 8.3 | 21.3% | 20.8% | 0.04 |
| INTLCONV | 506 | 3.7 | 40.2% | 37.6% | 0.24 |
| MCLEODRUSS | 506 | — | -10.5% | -164.9% | 33.57 |
| 523888 | 487 | 43.7 | -301224.5% | -415.1% | -1.00 |
| RUBFILA | 371 | 14.1 | 12.3% | 8.8% | 0.00 |
| HARRMALAYA | 354 | 13.1 | 15.6% | 17.6% | 0.65 |
⚠️ Risk Factors
1. Margin pressure from rupee depreciation and El Niño-related supply disruptions remains a concern, as explicitly flagged by management despite current stability in EBITDA per kg. 2. Expansion is contingent on capacity utilization exceeding 85%, meaning growth is not guaranteed and depends on execution timing, which could delay revenue acceleration. 3. Reliance on subsidiaries for future growth, as noted in investor takeaways, introduces execution and integration risks. 4. Limited visibility on long-term margin targets or ROCE improvement goals beyond current stability may constrain investor confidence if performance plateaus.
📋 Recent Filings
-
🔴 annual report 17 August 2026The filing announces the 65th Annual General Meeting (AGM) of CCL Products (India) Limited scheduled for September 8, 2026, via video conferencing, an...
-
🔴 Announcement 3 August 2026CCL Products (India) Limited announced the exercise of 4,200 employee stock options under its 2022 scheme, resulting in the issuance of shares at a fa...
-
🔴 Announcement 30 July 2026CCL Products (India) Limited announced that ICRA has assigned stable AA ratings to its long-term fund-based facilities totaling ₹1,155 crore and a sho...
-
🔴 Financial Results 30 July 2026CCL Products (India) reported Q1 FY27 revenue of **₹1,203.59 crores**, up 13.76% YoY, driven by 20% volume growth and strong branded sales targeting I...
-
🔴 Corporate Action 27 July 2026CCL Products announced a record date of September 1, 2026, for payment of a final dividend of Rs. 3 per equity share on the face value of Rs. 2, follo...
-
🟡 Board Meeting 27 July 2026The Board approved un-audited standalone and consolidated Q1 FY2026 results, declared a final dividend of Rs 3 per share with record date September 1,...
-
Announcement 27 July 2026CCL Products (India) announced un-audited standalone and consolidated financial results for Q1 June 2026, approved the 65th AGM for September 8, 2026,...
-
🔴 Financial Results 22 July 2026CCL Products (India) Limited announced a conference call on 28 July 2026 at 10:00 AM IST to discuss unaudited Q1 FY27 results, inviting analysts and i...
-
🔴 Announcement 21 July 2026CCL Products (India) Limited announced the exercise of 2,000 employee stock options under its 2022 scheme, resulting in the issuance of shares at a fa...
-
🟡 concall transcript 30 June 2026CCL Products (India) reported 13.76% YoY revenue growth to INR1,203.59 crores for Q1 FY27, driven by 20% volume growth and 21.84% EBITDA growth to INR...
🧠 Analyst's Read
CCL is executing a disciplined turnaround narrative: profitability is accelerating, debt is falling, and branded sales are scaling, but growth remains utilization-dependent and margin risks persist. Investors should monitor utilization trends, international expansion progress, and whether EBITDA per kg holds amid currency volatility — the next catalyst will be Q2 FY27 results and management’s update on capacity utilization trajectory.
Based on filing content and financial data. Not a recommendation.
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-02.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when CCL files new disclosures
Track CCL filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track CCL — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd